Cognitive Dysfunction
Conditions
Keywords
ketamine, midazolam, cognitive dysfunction
Brief summary
Deterioration of posoperative cognitive function (DCPO) is an intermediate state between normal cognitive aging and dementia, defined as a cognitive alteration greater than expected for the patient's age and educational level, but which doesn't interfere with the activities of daily life, in its evolution it can lead to dementia or it can present reversal of the deterioration with return to a normal cognitive state, or a stabilization with permanence in a state of moderate alteration. In general, higher cognitive function can be affected by organic or functional problems, anesthetic-surgical, diseases associated with the elderly and / or chronic-degenerative comorbidities. Older patients who undergo regional anesthesia have special interest, the adverse cardiovascular effects, or prolonged sedation due to a pharmacokinetics that is altered by age, call special attention to reduce complications in the postoperative period. In 2010 at the Siglo XXI Hospital in Mexico City, the 68-year-old population attended was 30% of those with postoperative cognitive dysfunction 26% a week, and 10% persistence at 3 months. The DSM V recommends a neuropsychiatric, psychological and cognitive evaluation of the patient in the postoperative period, through tests such as the Mini Mental State Examination. sub-anesthetic doses of ketamine have been recently proposed to reduce the postoperative markers of inflammation, pain and opioids, in addition to having an antidepressant effect. There is a pharmacological rationale for using ketamine as a preventative measure against postoperative delirium based on its N-methyl-D-aspartate (NMDA) antagonism, It has the potential to protect against such neurological injury.
Detailed description
Randomized double blind clinical trial. Male and female patients 60-90 years of age scheduled in elective surgery under regional anesthesia and sedation. The researchers will be double blind and the data analyzer will ignore the drug used ( it it should be midazolam or ketamine in an intravenous infusion). The principal investigator will limit himself to collecting the questionnaires and following up to 3 months. Simple finite randomization in two groups, will be done through envelopes. The pre-surgical, post-surgical Mini Mental questionnaire will be applied on the first day, 1 month and 3 months. During the trans-anesthetic, hemodynamic variables and anesthetic depth index measurements will be taken, surgical time, estimated bleeding, use of other adjuvant medications, type of surgery and comorbidities will be taken as intervening variables.
Interventions
DRUGketamine sedation versus midazolam sedation
Sedation with ketamine 5-20 mcg / kg / hr in infusion in 100ml Na Cl solution 0.9% during surgery and the second midazolam group 5 mcg- 35 mcg / kg / hr in infusion in 100ml Na Cl solution 0.9% will be administered during surgery
Sponsors
Instituto Mexicano del Seguro Social
Universidad de Colima
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Masking description
the participant, the researcher and the outcomes assesor don't know the drug used for sedation.
Intervention model description
Simple finite randomization will be performed. The anesthesiologist will choose an envelope with an assigned folio divided into two groups 1) intravenous infusion midazolam and 2) intravenous infusion ketamine, For sedation, regional anesthesia will be applied and hemodynamic variables, administered drugs, type of surgery, surgery time and transoperative bleeding will be recorded, after that, the cognitive evolution will be evaluated with the minimental examination at 3 months postoperatively
Eligibility
Sex/Gender
ALL
Age
60 Years to 85 Years
Healthy volunteers
Yes
Inclusion criteria
* age 60-90 years, * complete primary, * ASA I-II, * scheduled for non-urgent surgery, * to whom regional anesthesia and sedation are applied * sign the informed consent * Able to answer the brief examination of the mental state (MMSE ) preliminary with more than 24 points
Exclusion criteria
* not able to respond to MMSE, deaf-mute, blindness, * history of surgery the last 6 months, * use of pacemakers, * allergy to anesthetics, * use of psychiatric medication, or drugs, * diagnosed neurological disease (cerebrovascular disease, dementia, seizures) , * surgery scheduled for prostate resection, or reduction of hip fractures
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| cognitive function at baseline | It takes 30 minutes before the preparation of the surgery | the mini mental examination test will be done at baseline for the diagnostic |
| Change the cognitive function #1 | It Will be done at the hospital after one day of recovery | The minimental examination test Will be done after one day of the anesthesic procedure. |
| Change the cognitive function #2 | It Will be done at the patient home | The minimental examination test Will be done after one month of the anesthesic procedure. |
| Change the cognitive function#3 | It Will be done at the patient home three months after the surgery | The minimental examination test Will be done after three months of the anesthesic procedure. |
Countries
Mexico
Contacts
Primary Contactkarina Espinoza-Mejia, Msc
Backup ContactFabian Rojas-Larios, Phd
Outcome results
None listed